Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Francis

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Blood|July 29, 2018
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphomaTammy Linlin Song, Maarja-Liisa Nairismägi, Yurike Laurensia, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
American Journal of Hematology|June 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohortJing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Blood|July 29, 2018
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphomaTammy Linlin Song, Maarja-Liisa Nairismägi, Yurike Laurensia, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
American Journal of Hematology|June 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohortJing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, et al.
Pageof 6